Unique Ingredient Identifier SB8ZUX40TY is listed as a ingredient substance
RN | 6155-57-3 |
NCIT | C76516 |
RXCUI | 1305723 |
MF | C7H4NO3S.Na.2H2O |
INCHI KEY | AYGJDUHQRFKLBG-UHFFFAOYSA-M |
SMILES | O.O.[Na+].O=C1[N-]S(=O)(=O)C2=CC=CC=C12 |
UNII SB8ZUX40TY SACCHARIN SODIUM is commonly included in medications in the following forms.
Route | Dosage Form | Potency |
---|---|---|
BUCCAL | FILM | 2.99 MG |
BUCCAL | FILM, SOLUBLE | 0.57 MG |
BUCCAL/SUBLINGUAL | TABLET | 0.4 MG |
DENTAL | GEL | 0.3 % |
DENTAL | OINTMENT | NA |
DENTAL | PASTE | NA |
DENTAL | SOLUTION | 0.15 % |
IM - IV | INJECTION | 0.09 % |
INHALATION | AEROSOL, METERED | 0.045 % |
INHALATION | SOLUTION | NA |
INTRAMUSCULAR | INJECTION | 0.9 mg/1mL |
INTRAMUSCULAR | INJECTION | 0.09 %W/V |
INTRAVENOUS | INJECTION | 0.9 mg/1mL |
INTRAVENOUS | INJECTION | 0.09 % |
IV(INFUSION) | INJECTION | 0.09 % |
ORAL | CAPSULE | 2.02 MG |
ORAL | CAPSULE, SOFT GELATIN | 0.51 MG |
ORAL | CONCENTRATE | 1.5 MG/1ML |
ORAL | DISPERSIBLE TABLET | 0.5 MG |
ORAL | EMULSION | NA |
ORAL | GRANULE, for ORAL SOLUTION | 5.5 MG/SACHET |
ORAL | LIQUID | 6 MG/ML |
ORAL | POWDER | 0.003 MG |
ORAL | POWDER, FOR ORAL SOLUTION | 60 MG |
ORAL | POWDER, FOR ORAL SUSPENSION | 5 MG/5ML |
ORAL | POWDER, FOR RECONSTITUTION | 290 MG/1BOT |
ORAL | POWDER, FOR SOLUTION | 391.9 MG/1BOT |
ORAL | POWDER, FOR SUSPENSION | 32.5 MG/5ML |
ORAL | SOLUTION | 35 MG/5ML |
ORAL | SOLUTION | 30 mg/5 mL |
ORAL | SOLUTION | 15 MG |
ORAL | SOLUTION, ELIXIR | 15 MG/5ML |
ORAL | SOLUTION, LIQUID | 3 MG/1ML |
ORAL | SOLUTION, SYRUP | 6 MG/1ML |
ORAL | SUSPENSION | 20 mg/5mL |
ORAL | SUSPENSION | 2.5 mg/1mL |
ORAL | SUSPENSION, LIQUID | 2.5 MG/5ML |
ORAL | SYRUP | 50 MG/5ML |
ORAL | TABLET | 20 MG |
ORAL | TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE | 9 MG |
ORAL | TABLET, CHEWABLE | 5 MG |
ORAL | TABLET, FILM COATED | 2 MG |
ORAL | TABLET, ORALLY DISINTEGRATING | 2.5 MG |
RECTAL | SOLUTION | 0.085 % |
RECTAL | SUSPENSION | 0.036 % |
RECTAL | TABLET | 0.6 MG |
SUBLINGUAL | TABLET | 6.5 MG |
TOPICAL | OINTMENT | NA |